Concepedia

Srini Ramanathan

SR

Statistics

Publications

14

Citations

950

H-Index

12

Active since

2013

Affiliations

Gilead Sciences (United States)(Current)

Orlando Immunology Center

CTI BioPharma (United States)

Horizon Therapeutics (United States)

Srini Ramanathan is an author at Gilead Sciences (United States) specializing in pharmacology, clinical pharmacology, and pharmacokinetics.

Publications per year

2013–2022

14

Publications

14

Oral GS-5806 Activity in a Respiratory Syncytial Virus Challenge Study

John P. DeVincenzo, Richard J. Whitley, Richard L. Mackman et al. · New England Journal of Medicine · 2014 · 337 citations · Full text

, , +12

Antiviral Activity, Safety, and Pharmacokinetics/Pharmacodynamics of Tenofovir Alafenamide as 10-Day Monotherapy in HIV-1–Positive Adults

Peter Ruane, Edwin DeJesus, Daniel Berger et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes · 2013 · 307 citations

, , +17

Efficacy and Safety 48 Weeks after Switching from Efavirenz to Rilpivirine Using Emtricitabine/Tenofovir Disoproxil Fumarate–Based Single-Tablet Regimens

Anthony Mills, Calvin Cohen, Edwin DeJesus et al. · HIV Clinical Trials · 2013 · 71 citations · Full text

, , +15

Clinical drug interaction profile of idelalisib in healthy subjects

Feng Jin, Michelle Robeson, Huafeng Zhou et al. · The Journal of Clinical Pharmacology · 2015 · 48 citations

, , +17

The pharmacokinetics and safety of idelalisib in subjects with moderate or severe hepatic impairment

Feng Jin, Michelle Robeson, Huafeng Zhou et al. · The Journal of Clinical Pharmacology · 2015 · 28 citations

, , +13

1–5 of 14